Bristol-Myers Squibb (BMY) to announce Q4 earnings on February 6th. Analysts expect $1.47 EPS on $11.56B revenue.

Consumer staples are known for their stability during market volatility, as demand for essential goods remains consistent.

LOS ANGELES, CA / ACCESS Newswire / February 5, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a ...

In recent transactions involving abrdn Life Sciences Investors (NYSE:HQL), significant sales of common stock were reported by ...

Palantir Technologies (NYSE:PLTR) has been a lightning rod for investor debate over the past few quarters as the stock has ...

Chevron is holding talks with the Trump administration amid calls by top Republican officials for the company to exit the ...

To list the 10 Best Wide Moat Stocks to Invest In, we scanned through VanEck Morningstar Wide Moat ETF and some online ...

It reported sales of $4.0 billion and adjusted earnings of $0.62 per share, compared to the consensus estimates of $4.0 ...

Lumen Technologies' exceeded Q4 earnings and revenue expectations. Check out why I think LUMN stock is a long-term investment ...

We recently published a list of 15 Best Dividend Stocks To Buy and Hold. In this article, we are going to take a look at ...

Since the beginning of 2024, PFE stock has underperformed the S&P 500 index, delivering -3% returns compared to the index’s ...

Wall Street shifted lower in early trading Wednesday as markets took in more corporate earnings reports while considering the ...